{"schema_version":"alpha-company-profile-public-v2","slug":"adagene-inc","canonical_url":"https://registry.alpha.ac/companies/adagene-inc","published_on":"2026-09-12T21:32:05.800844+00:00","last_reviewed_on":"2026-09-12T21:32:05.800844+00:00","identity":{"legal_name":"Adagene Inc.","display_name":"Adagene Inc.","headline":"Adagene Inc. functions as a clinical-stage biopharmaceutical organization, primarily concentrating on the identification, evolution, and fabrication of monoclonal antibody-based therapeutics engineered to combat various types of cancer.","description":"Adagene Inc. functions as a clinical-stage biopharmaceutical organization, primarily concentrating on the identification, evolution, and fabrication of monoclonal antibody-based therapeutics engineered to combat various types of cancer. The company's developmental pipeline encompasses several investigational assets currently undergoing human trials. Among these is ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibody, which is navigating Phase 1b/2 clinical assessment for indi","ten_second_view":"This Company Profile publishes only Alpha's canonical identity and evidence-backed public leadership records. Unavailable fields are not inferred.","legal_form":"Not publicly asserted","incorporation":"Not publicly asserted","headquarters":"US","headquarters_address":{"locality":"Not publicly asserted","region":null,"country":"US"},"operating_presence":["US"],"website":"","cik":"0001818838","logo":"https://cdn.brandfetch.io/ticker/adag/theme/dark/fallback/404/type/logo?c=1idgAB6rG5KFT5I7q5w","logo_source":"brandfetch","profile_mark":{"src":"https://cdn.brandfetch.io/ticker/adag/theme/dark/fallback/404/type/logo?c=1idgAB6rG5KFT5I7q5w","alt":"Adagene Inc. logo","width":256,"height":256,"source":"brandfetch"}},"entity_status":{"ownership_type":"unknown","listing_status":"listed","label":"Public listing published","explanation":"The canonical public record includes at least one active security listing.","source_id":"alpha-canonical-company-record","reviewed_on":"2026-09-12T21:32:05.800844+00:00"},"security_listings":[{"ticker":"ADAG","exchange":"NASDAQ","exchange_display":"NASDAQ","mic":"XNAS","currency":"Unavailable","security_type":"equity","listing_status":"active","is_primary":true,"source_id":"alpha-canonical-company-record"}],"market_data":{"availability":"unavailable","endpoint":null,"source_label":null,"explanation":"Market data is not published in this Company Profile."},"profile_tags":["Canonical identity","Public leadership"],"trust_summary":"Canonical identity published; broader company intelligence is not asserted.","facts":[{"label":"Legal name","value":"Adagene Inc.","source_id":"alpha-canonical-company-record"},{"label":"Country","value":"US","source_id":"alpha-canonical-company-record"},{"label":"Sector","value":"Healthcare","source_id":"alpha-canonical-company-record"},{"label":"Industry","value":"Biotechnology","source_id":"alpha-canonical-company-record"}],"operating_model":{"eyebrow":"Operating record","title":"Published operating structure","units":[]},"governance":{"summary":"Only current, confirmed leadership roles with public evidence are included in the canonical projection.","boundary":"Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","disclosures":[]},"alpha_opinion":{"status":"Not published","label":"No Alpha opinion published","explanation":"This identity record is not an Alpha rating, score, or investment opinion."},"report":{"status":"Not published","label":"No governed report published","explanation":"No governed company report is attached to this profile.","href":null},"actions":[],"related_records":[],"evidence":[{"id":"alpha-canonical-company-record","label":"Alpha canonical company public projection","href":"/api/public/companies/adagene-inc","source_type":"canonical_identity","supports":["Company identity","Published leadership","Entity status boundary"],"status":"published","reviewed_on":"2026-09-12T21:32:05.800844+00:00"}],"permissions":[{"label":"Public retrieval","allowed":true},{"label":"Agent retrieval","allowed":true},{"label":"Redistribution","allowed":false},{"label":"Model training","allowed":false},{"label":"Relationship pathfinding","allowed":false},{"label":"Direct contact","allowed":false}],"limitations":["Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":22,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":22,"under_review_claim_count":1,"owner_supplied_claim_count":0,"evidence_record_count":2,"distinct_source_count":2,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":22,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":22,"corroborated_claims":0,"sources":2,"distinct_sources":2,"role_claims":0,"last_reviewed_at":"2026-09-12T21:32:05.800844+00:00","observed_at":"2026-09-12T21:32:05.800844+00:00","freshness_days":0}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"company","slug":"adagene-inc","canonical_url":"https://registry.alpha.ac/companies/adagene-inc"},"publication":{"published_at":"2026-09-12T21:32:05.800844+00:00","last_reviewed_at":"2026-09-12T21:32:05.800844+00:00","as_of":"2026-09-12T21:32:05.800844+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/companies/adagene-inc","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/companies/adagene-inc","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/companies/adagene-inc.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}},"canonical_profile":{"schema_version":"alpha-company-profile-public-v1","slug":"adagene-inc","canonical_url":"https://registry.alpha.ac/companies/adagene-inc","as_of":"2026-09-12T21:32:05.800844+00:00","last_reviewed_at":"2026-09-12T21:32:05.800844+00:00","identity":{"legal_name":"Adagene Inc.","display_name":"Adagene Inc.","description":"Adagene Inc. functions as a clinical-stage biopharmaceutical organization, primarily concentrating on the identification, evolution, and fabrication of monoclonal antibody-based therapeutics engineered to combat various types of cancer. The company's developmental pipeline encompasses several investigational assets currently undergoing human trials. Among these is ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibody, which is navigating Phase 1b/2 clinical assessment for indi","jurisdiction":null,"country":"US","sector":"Healthcare","industry":"Biotechnology","website":null,"website_provenance":null,"logo_url":null,"logo_media":null,"status":"active","cik":"0001818838","entity_subtype":null,"legal_entity_status":null},"security_listings":[{"mic":"XNAS","ticker":"ADAG","currency":null,"exchange":"NASDAQ","sort_key":0,"valid_to":null,"confidence":0.95,"is_primary":true,"listing_id":"22af32da-2082-44f7-9049-34e08bb2d486","source_url":"https://www.sec.gov/files/company_tickers_exchange.json","valid_from":null,"observed_at":"2026-07-11T00:28:32+00:00","source_name":"sec_company_tickers_exchange","source_tier":1,"exchange_name":"NASDAQ","security_type":"equity","listing_status":"active","last_checked_at":"2026-09-02T01:48:40.989053+00:00"}],"market_data":{"availability":"unavailable","endpoint":null,"source_label":null,"explanation":"Market observations are unpublished. Listing identity remains available from the governed source set."},"index_memberships":[],"index_membership_history":[],"index_membership_contract":{"schema_version":"alpha-index-membership-public-v1","as_of_date":"2026-09-13","tracked_universe_complete":false,"permissions":{"public_retrieval":true,"agent_retrieval":false,"redistribution":false,"model_training":false},"limitations":["Only source-backed memberships with an explicit public redistribution basis are returned.","Absence from Alpha tracked indices does not establish absence from every market index.","Provider announcements and effective membership are represented as distinct states.","Alpha AI 100 is not published as a current public index membership."]},"leadership":{"board":[{"person_slug":"peter-luo-ph-d","display_name":"Peter Luo, Ph.D","role_category":"director","title":"Co-Founder, Chief Executive Officer, President of R&D, and Chairman of the Board","committee":null,"is_board_chair":true,"is_independent":false,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001104659-26-038612","source_url":"https://www.sec.gov/Archives/edgar/data/1818838/000110465926038612/adag-20251231x20f.htm","source_type":"sec_20f","published_at":"2026-04-01T00:00:00+00:00","effective_date":"2026-04-01","last_checked_at":"2026-09-05T21:51:05.837618+00:00"},"headshot_url":null},{"person_slug":"andy-yiu-leung-cheung","display_name":"Andy (Yiu Leung) Cheung","role_category":"director","title":"Independent Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001104659-26-038612","source_url":"https://www.sec.gov/Archives/edgar/data/1818838/000110465926038612/adag-20251231x20f.htm","source_type":"sec_20f","published_at":"2026-04-01T00:00:00+00:00","effective_date":"2026-04-01","last_checked_at":"2026-09-05T21:51:05.837618+00:00"},"headshot_url":null},{"person_slug":"cuong-do-adagene-inc","display_name":"Cuong Do","role_category":"director","title":"Independent Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001104659-26-038612","source_url":"https://www.sec.gov/Archives/edgar/data/1818838/000110465926038612/adag-20251231x20f.htm","source_type":"sec_20f","published_at":"2026-04-01T00:00:00+00:00","effective_date":"2026-04-01","last_checked_at":"2026-09-05T21:51:05.837618+00:00"},"headshot_url":null},{"person_slug":"li-zhu-ph-d","display_name":"Li Zhu, Ph.D.","role_category":"director","title":"Independent Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001104659-26-038612","source_url":"https://www.sec.gov/Archives/edgar/data/1818838/000110465926038612/adag-20251231x20f.htm","source_type":"sec_20f","published_at":"2026-04-01T00:00:00+00:00","effective_date":"2026-04-01","last_checked_at":"2026-09-05T21:51:05.837618+00:00"},"headshot_url":null},{"person_slug":"man-kin-raymond-tam-m-b-a-b-eng","display_name":"Man Kin (Raymond) Tam, M.B.A., B. Eng.","role_category":"director","title":"Chief Financial Officer and Director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001104659-26-038612","source_url":"https://www.sec.gov/Archives/edgar/data/1818838/000110465926038612/adag-20251231x20f.htm","source_type":"sec_20f","published_at":"2026-04-01T00:00:00+00:00","effective_date":"2026-04-01","last_checked_at":"2026-09-05T21:51:05.837618+00:00"},"headshot_url":null},{"person_slug":"ulf-grawunder-ph-d","display_name":"Ulf Grawunder, Ph.D.","role_category":"director","title":"Independent Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001104659-26-038612","source_url":"https://www.sec.gov/Archives/edgar/data/1818838/000110465926038612/adag-20251231x20f.htm","source_type":"sec_20f","published_at":"2026-04-01T00:00:00+00:00","effective_date":"2026-04-01","last_checked_at":"2026-09-05T21:51:05.837618+00:00"},"headshot_url":null}],"executives":[{"person_slug":"alexander-goergen","display_name":"Alexander Goergen","role_category":"executive","title":"Vice President, Head of Business Development","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001104659-26-038612","source_url":"https://www.sec.gov/Archives/edgar/data/1818838/000110465926038612/adag-20251231x20f.htm","source_type":"sec_20f","published_at":"2026-04-01T00:00:00+00:00","effective_date":"2026-04-01","last_checked_at":"2026-09-05T21:51:05.837618+00:00"},"headshot_url":null},{"person_slug":"guizhong-liu-ph-d","display_name":"Guizhong Liu, Ph.D.","role_category":"executive","title":"Senior Vice President of Early Drug Discovery","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001104659-26-038612","source_url":"https://www.sec.gov/Archives/edgar/data/1818838/000110465926038612/adag-20251231x20f.htm","source_type":"sec_20f","published_at":"2026-04-01T00:00:00+00:00","effective_date":"2026-04-01","last_checked_at":"2026-09-05T21:51:05.837618+00:00"},"headshot_url":null},{"person_slug":"jiping-zha","display_name":"Jiping Zha","role_category":"executive","title":"Executive Vice President of Clinical Development","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001104659-26-038612","source_url":"https://www.sec.gov/Archives/edgar/data/1818838/000110465926038612/adag-20251231x20f.htm","source_type":"sec_20f","published_at":"2026-04-01T00:00:00+00:00","effective_date":"2026-04-01","last_checked_at":"2026-09-05T21:51:05.837618+00:00"},"headshot_url":null},{"person_slug":"man-kin-raymond-tam-m-b-a-b-eng","display_name":"Man Kin (Raymond) Tam, M.B.A., B. Eng.","role_category":"executive","title":"Chief Financial Officer and Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001104659-26-038612","source_url":"https://www.sec.gov/Archives/edgar/data/1818838/000110465926038612/adag-20251231x20f.htm","source_type":"sec_20f","published_at":"2026-04-01T00:00:00+00:00","effective_date":"2026-04-01","last_checked_at":"2026-09-05T21:51:05.837618+00:00"},"headshot_url":null},{"person_slug":"mickael-chane-du","display_name":"Mickael Chane-Du","role_category":"executive","title":"Chief Strategy Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001104659-26-038612","source_url":"https://www.sec.gov/Archives/edgar/data/1818838/000110465926038612/adag-20251231x20f.htm","source_type":"sec_20f","published_at":"2026-04-01T00:00:00+00:00","effective_date":"2026-04-01","last_checked_at":"2026-09-05T21:51:05.837618+00:00"},"headshot_url":null},{"person_slug":"peter-luo-ph-d","display_name":"Peter Luo, Ph.D","role_category":"executive","title":"Co-Founder, Chief Executive Officer, President of R&D, and Chairman of the Board","committee":null,"is_board_chair":true,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001104659-26-038612","source_url":"https://www.sec.gov/Archives/edgar/data/1818838/000110465926038612/adag-20251231x20f.htm","source_type":"sec_20f","published_at":"2026-04-01T00:00:00+00:00","effective_date":"2026-04-01","last_checked_at":"2026-09-05T21:51:05.837618+00:00"},"headshot_url":null},{"person_slug":"qinghai-zhao-ph-d","display_name":"Qinghai Zhao, Ph.D","role_category":"executive","title":"Chief Manufacturing Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001104659-26-038612","source_url":"https://www.sec.gov/Archives/edgar/data/1818838/000110465926038612/adag-20251231x20f.htm","source_type":"sec_20f","published_at":"2026-04-01T00:00:00+00:00","effective_date":"2026-04-01","last_checked_at":"2026-09-05T21:51:05.837618+00:00"},"headshot_url":null},{"person_slug":"songmao-zheng-ph-d","display_name":"Songmao Zheng, Ph.D.","role_category":"executive","title":"Senior Vice President of Clinical Pharmacology and Quantitative Sciences","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001104659-26-038612","source_url":"https://www.sec.gov/Archives/edgar/data/1818838/000110465926038612/adag-20251231x20f.htm","source_type":"sec_20f","published_at":"2026-04-01T00:00:00+00:00","effective_date":"2026-04-01","last_checked_at":"2026-09-05T21:51:05.837618+00:00"},"headshot_url":null},{"person_slug":"wenlin-zeng","display_name":"Wenlin Zeng","role_category":"executive","title":"Vice President of Early Stage CMC","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001104659-26-038612","source_url":"https://www.sec.gov/Archives/edgar/data/1818838/000110465926038612/adag-20251231x20f.htm","source_type":"sec_20f","published_at":"2026-04-01T00:00:00+00:00","effective_date":"2026-04-01","last_checked_at":"2026-09-05T21:51:05.837618+00:00"},"headshot_url":null},{"person_slug":"xiaohong-kristine-she","display_name":"Xiaohong (Kristine) She","role_category":"executive","title":"Senior Vice President, Head of Clinical Operations","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001104659-26-038612","source_url":"https://www.sec.gov/Archives/edgar/data/1818838/000110465926038612/adag-20251231x20f.htm","source_type":"sec_20f","published_at":"2026-04-01T00:00:00+00:00","effective_date":"2026-04-01","last_checked_at":"2026-09-05T21:51:05.837618+00:00"},"headshot_url":null},{"person_slug":"yan-li-m-b-a","display_name":"Yan Li, M.B.A.","role_category":"executive","title":"Senior Vice President, Bioinformatics and Information Technology","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC 20-F 0001104659-26-038612","source_url":"https://www.sec.gov/Archives/edgar/data/1818838/000110465926038612/adag-20251231x20f.htm","source_type":"sec_20f","published_at":"2026-04-01T00:00:00+00:00","effective_date":"2026-04-01","last_checked_at":"2026-09-05T21:51:05.837618+00:00"},"headshot_url":null}],"coverage":{"schema_version":"alpha-leadership-coverage-v1","board_roster_scope":"def_14a_current_directors","executive_roster_scope":"disclosed_officers_only","neo_set_status":"NOT_ASSERTED","board_roster_complete":false,"neo_set_complete":false,"notes":["Empty executives is NOT_ASSERTED, not a complete named-executive-officer set.","Form 4 occupancy is not a DEF 14A board.","Unconfirmed current sec_proxy DEF 14A directors may project. Confirmed is not required.","Unconfirmed current executives with first-party issuer evidence (source_url + effective date) may project.","Company-page directors do not require people.public_profile_enabled.","Completeness compares the latest first-party roster with the public projection; a source older than 180 days is STALE.","Do not remap HONA to HON 0000773840. Do not merge XOM 0000034088 with 0002115436.","Person match is projection-only. Name-only Person merges are forbidden."],"completeness":{"reasons":["NO_LEADERSHIP_SOURCE"],"board_completeness":"NOT_REVIEWED","completeness_schema":"alpha-leadership-completeness-v1","executive_team_completeness":"NOT_REVIEWED"},"parser_bleed_excluded":true,"former_titles_excluded":true,"identity_merge_forbidden":true,"form4_occupancy_is_not_board":true}},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"structured_data":{"@context":["https://schema.org",{"alpha":"https://alpha.ac/ns/","indexMembership":"alpha:indexMembership","indexProvider":"alpha:indexProvider","indexMembershipStatus":"alpha:indexMembershipStatus","indexEffectiveDate":"alpha:indexEffectiveDate","indexAnnouncementDate":"alpha:indexAnnouncementDate","indexRemovalDate":"alpha:indexRemovalDate","lastVerifiedAt":"alpha:lastVerifiedAt","verificationStatus":"alpha:verificationStatus","evidence":"alpha:evidence"}],"@type":"ProfilePage","@id":"https://registry.alpha.ac/companies/adagene-inc#profile","url":"https://registry.alpha.ac/companies/adagene-inc","dateModified":"2026-09-12T21:32:05.800844+00:00","mainEntity":{"@type":"Organization","@id":"https://registry.alpha.ac/companies/adagene-inc#organization","legalName":"Adagene Inc.","name":"Adagene Inc.","description":"Adagene Inc. functions as a clinical-stage biopharmaceutical organization, primarily concentrating on the identification, evolution, and fabrication of monoclonal antibody-based therapeutics engineered to combat various types of cancer. The company's developmental pipeline encompasses several investigational assets currently undergoing human trials. Among these is ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibody, which is navigating Phase 1b/2 clinical assessment for indi","url":"https://registry.alpha.ac/companies/adagene-inc","addressCountry":"US","indexMembership":[],"member":[{"@type":"OrganizationRole","roleName":"Co-Founder, Chief Executive Officer, President of R&D, and Chairman of the Board","member":{"@type":"Person","name":"Peter Luo, Ph.D","url":"https://registry.alpha.ac/people/peter-luo-ph-d"}},{"@type":"OrganizationRole","roleName":"Independent Director","member":{"@type":"Person","name":"Andy (Yiu Leung) Cheung","url":"https://registry.alpha.ac/people/andy-yiu-leung-cheung"}},{"@type":"OrganizationRole","roleName":"Independent Director","member":{"@type":"Person","name":"Cuong Do","url":"https://registry.alpha.ac/people/cuong-do-adagene-inc"}},{"@type":"OrganizationRole","roleName":"Independent Director","member":{"@type":"Person","name":"Li Zhu, Ph.D.","url":"https://registry.alpha.ac/people/li-zhu-ph-d"}},{"@type":"OrganizationRole","roleName":"Chief Financial Officer and Director","member":{"@type":"Person","name":"Man Kin (Raymond) Tam, M.B.A., B. Eng.","url":"https://registry.alpha.ac/people/man-kin-raymond-tam-m-b-a-b-eng"}},{"@type":"OrganizationRole","roleName":"Independent Director","member":{"@type":"Person","name":"Ulf Grawunder, Ph.D.","url":"https://registry.alpha.ac/people/ulf-grawunder-ph-d"}},{"@type":"OrganizationRole","roleName":"Vice President, Head of Business Development","member":{"@type":"Person","name":"Alexander Goergen","url":"https://registry.alpha.ac/people/alexander-goergen"}},{"@type":"OrganizationRole","roleName":"Senior Vice President of Early Drug Discovery","member":{"@type":"Person","name":"Guizhong Liu, Ph.D.","url":"https://registry.alpha.ac/people/guizhong-liu-ph-d"}},{"@type":"OrganizationRole","roleName":"Executive Vice President of Clinical Development","member":{"@type":"Person","name":"Jiping Zha","url":"https://registry.alpha.ac/people/jiping-zha"}},{"@type":"OrganizationRole","roleName":"Chief Financial Officer and Director","member":{"@type":"Person","name":"Man Kin (Raymond) Tam, M.B.A., B. Eng.","url":"https://registry.alpha.ac/people/man-kin-raymond-tam-m-b-a-b-eng"}},{"@type":"OrganizationRole","roleName":"Chief Strategy Officer","member":{"@type":"Person","name":"Mickael Chane-Du","url":"https://registry.alpha.ac/people/mickael-chane-du"}},{"@type":"OrganizationRole","roleName":"Co-Founder, Chief Executive Officer, President of R&D, and Chairman of the Board","member":{"@type":"Person","name":"Peter Luo, Ph.D","url":"https://registry.alpha.ac/people/peter-luo-ph-d"}},{"@type":"OrganizationRole","roleName":"Chief Manufacturing Officer","member":{"@type":"Person","name":"Qinghai Zhao, Ph.D","url":"https://registry.alpha.ac/people/qinghai-zhao-ph-d"}},{"@type":"OrganizationRole","roleName":"Senior Vice President of Clinical Pharmacology and Quantitative Sciences","member":{"@type":"Person","name":"Songmao Zheng, Ph.D.","url":"https://registry.alpha.ac/people/songmao-zheng-ph-d"}},{"@type":"OrganizationRole","roleName":"Vice President of Early Stage CMC","member":{"@type":"Person","name":"Wenlin Zeng","url":"https://registry.alpha.ac/people/wenlin-zeng"}},{"@type":"OrganizationRole","roleName":"Senior Vice President, Head of Clinical Operations","member":{"@type":"Person","name":"Xiaohong (Kristine) She","url":"https://registry.alpha.ac/people/xiaohong-kristine-she"}},{"@type":"OrganizationRole","roleName":"Senior Vice President, Bioinformatics and Information Technology","member":{"@type":"Person","name":"Yan Li, M.B.A.","url":"https://registry.alpha.ac/people/yan-li-m-b-a"}}]},"mainEntityOfPage":"https://registry.alpha.ac/companies/adagene-inc"}},"canonical_source":"aegis_canonical"}